Veerhealth Care Ltd has announced that its board of directors will meet on Saturday, May 30, 2026, to discuss the company's financial performance for the recent period. The meeting is scheduled to take place at 11:00 A.M. at the company's registered office in Mumbai.

Agenda for the Meeting

The primary agenda for the board meeting includes the consideration and approval of the audited financial results for the quarter and financial year ended March 31, 2026. Alongside the results, the board will also evaluate the recommendation of a dividend, subject to the financial outcomes.

Trading Window Update

In a separate disclosure regarding regulatory compliance, the company informed the stock exchanges about the status of its trading window. The window for dealing in the securities of the company was closed from April 1, 2026. Pursuant to SEBI regulations, the trading window is set to reopen on June 2, 2026.

Key Meeting Details

The following table summarizes the key details regarding the upcoming board meeting and the trading window schedule:

The meeting will be held at 629-A Gazdar House, 1st Floor, J.S.S. Marg, Near Kalbadevi Post Office, Mumbai- 400002. The intimation was sent to BSE Limited pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Veerhealth Care Limited has secured a repeat order worth ₹2.45 Crores from one of India's leading FMCG companies for the supply of personal care products. The announcement was made on May 18, 2026, in compliance with Regulation 30 of the SEBI (LODR) Regulations, 2015.

Order Details

The order pertains to the supply of face care products to a domestic entity. The identity of the client has not been revealed, as the terms of the arrangement are confidential. The company is required to execute the order within a stipulated timeframe of 45 days. The buyer operates in the domestic and international markets in the 'personal and household care' segment and is part of a 125-year-old prominent business group.

The key parameters of the order are summarised below:

Future Outlook

Veerhealth Care specializes in manufacturing pure vegetarian toothpaste and has secured USFDA plant clearance, positioning it in a distinctive category among small-cap companies. For the fiscal year 2026-27, the company expects total revenues of ₹50-70 crores with a PAT of 7-10%. However, considering ongoing discussions for orders with both domestic and export buyers, revenues may exceed this guidance. The company anticipates reaching a revenue of ₹100 crores with a PAT of 10% in the next 24 months.